Whales accumulate Hyperliquid during the dip, not the rally – Why?

ambcryptoPublished on 2025-12-23Last updated on 2025-12-23

Abstract

Hyperliquid's large holders (whales) have aggressively accumulated over $21.5M worth of HYPE during the recent price decline, not during rallies, indicating strong conviction. This accumulation, combined with persistent negative exchange outflows, suggests selling pressure is being absorbed and available supply is shrinking. Price action shows HYPE compressing within a descending wedge near key support around $22, with oversold conditions and weakening bearish momentum. Top trader positioning leans long, and funding rates have stabilized, indicating a leverage reset. These converging factors—whale buying, reduced sell supply, cooling leverage, and chart compression—significantly alter the risk profile near support, increasingly favoring a potential relief-driven reversal rather than further downside.

Hyperliquid’s large holders have stepped in aggressively during the recent decline, adding clear numerical weight to the accumulation narrative.

Whales accumulated 427,441 HYPE worth $11.58M at an average $27.09 over two months, while another added 398,830 HYPE worth $10M around $25.22 in just five days.

Combined, whale accumulation now exceeds $21.5M near the current price range.

Importantly, this buying occurred as price slid toward the $22–$24 zone, not during upside expansion. That behavior typically reflects conviction rather than momentum chasing.

Moreover, whales accumulated above current price yet continue holding. Therefore, downside pressure appears absorbed rather than accelerated.

This activity does not guarantee an immediate reversal. However, it significantly alters the risk profile near support.

Is the descending wedge nearing resolution?

HYPE continues to compress inside a well-defined descending wedge, with price trading just above the lower boundary near $22.26.

This structure reflects weakening bearish momentum rather than strong trend continuation.

The RSI was 35.26 at press time, with its moving average near 34.12, showing oversold conditions without fresh downside expansion.

Importantly, recent candles show shallower lows compared to earlier declines from $48 and $35.92. That change suggests sellers lose control incrementally.

However, resistance remains layered. The first reaction level sits near $29.94, while a broader breakout zone aligns closer to $35.92.

Therefore, while downside exhaustion builds, confirmation still requires structure resolution. Volatility expansion now appears increasingly asymmetric toward the upside.

HYPE tightens available sell supply

Spot exchange netflows continue flashing negative, reinforcing accumulation behavior beyond price action alone.

On the 23rd of December, HYPE price recorded a net outflow of approximately -$971K, extending a broader trend of persistent withdrawals.

Earlier periods showed even deeper outflows exceeding -$30M to -$50M, highlighting heavy distribution already completed. Crucially, netflows have not flipped positive despite price weakness.

That consistency matters. When assets leave exchanges during declines, holders usually reduce immediate selling intent. Therefore, available liquid supply continues shrinking near current levels.

This dynamic does not trigger reversals instantly. However, it increases price sensitivity to demand shifts.

As a result, even modest buying pressure can produce outsized reactions once structure breaks.

Top traders lean long into uncertainty

Binance top trader positioning shows a clear long bias despite ongoing price weakness.

As of the 23rd of December, 61.65% of top trader accounts remained long, while 38.35% held short positions, producing a long/short ratio near 1.61.

This bias persisted as price traded near $24, rather than unwinding aggressively. That behavior suggests expectations of a reaction rather than continuation.

Importantly, positioning does not appear excessively crowded. Ratios remain below extreme optimism thresholds seen earlier in the trend.

Therefore, professional traders show controlled confidence rather than blind conviction.

When combined with whale accumulation, this positioning supports the idea that downside risk now faces increasing resistance near support.

HYPE funding resets as leverage pressure fades

Hyperliquid’s OI-Weighted Funding Rate reflected a clear cooldown in speculative positioning. At the latest reading, funding sat near 0.0047%, remaining slightly positive without spiking.

Earlier periods showed sharp negative dips below -0.02%, signaling forced unwinds.

That phase now appears complete. Current funding stability suggests leverage has reset rather than flipped aggressively bearish.

This balance matters because it reduces liquidation-driven volatility. Moreover, neutral funding allows spot flows to dictate price direction more cleanly.

Therefore, any breakout attempt from the descending wedge may develop without heavy derivative friction. In many historical setups, such resets precede structural reversals rather than continuation.

In summary, HYPE price sits at a critical inflection zone where accumulation, falling exchange supply, stabilizing leverage, and wedge compression converge.

While confirmation still matters, conditions increasingly favor a relief-driven reversal rather than renewed downside acceleration.


Final Thoughts

  • Whale accumulation and falling exchange supply reduce downside pressure near key support.
  • Cooling leverage and wedge compression increase the probability of a relief-driven move.

Trending Cryptos

Related Questions

QAccording to the article, why do whales accumulate Hyperliquid (HYPE) during the dip rather than the rally?

AWhales accumulate during the dip because it reflects conviction and a long-term strategy, rather than chasing short-term momentum. Their aggressive buying as the price slid toward the $22–$24 zone suggests they believe the asset is undervalued at those levels.

QWhat is the significance of the descending wedge pattern mentioned for HYPE's price?

AThe descending wedge pattern reflects weakening bearish momentum, not a strong trend continuation. It suggests that sellers are incrementally losing control, and a breakout from this structure is increasingly likely to be to the upside.

QHow do negative netflows from spot exchanges impact the available supply of HYPE?

APersistent negative netflows, where more HYPE is withdrawn from exchanges than deposited, indicate that holders are moving their assets into custody, reducing the immediate selling pressure and tightening the available liquid supply on the market.

QWhat does the positioning of Binance's top traders reveal about market sentiment towards HYPE?

AAs of December 23rd, 61.65% of top trader accounts were long on HYPE, showing a clear long bias despite price weakness. This suggests professional traders expect a price reaction and reversal rather than a continued downtrend.

QWhat does a neutral funding rate indicate for Hyperliquid's market, according to the article?

AA neutral funding rate near 0.0047% indicates that speculative leverage has reset and stabilized. This reduces the risk of liquidation-driven volatility and allows spot market flows to dictate price direction more cleanly, often preceding a structural reversal.

Related Reads

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

On August 18th, Haowei Huaxin, a semiconductor firm specializing in gallium arsenide and gallium nitride wafers, reported that over a hundred individuals forcibly entered its offices and seized the company's official seals from a safe, including the corporate, contract, and party committee seals. The incident is the latest escalation in a protracted control dispute. Haowei Huaxin, established in 2010, was originally a joint venture. Control became contested after 2021 when Zhenwei Financial Holding injected capital, becoming the largest shareholder (34.01%), while former parent Haite High-Tech's stake was diluted to 33.79%. An agreed-upon governance structure collapsed, leading to mutual accusations. Haite claimed it was locked out of the subsidiary's premises, while also alleging improper management like livestock being kept on the chip fabrication site. After state-owned Qingdao Haiyue Holdings took over Zhenwei's stake in 2023, Haite accused it of illegally seizing control. Despite Haite winning several legal battles in 2024-2026, which affirmed its rights to nominate directors and the chairman, it failed to regain physical control or recover the seals. The stakes are high: market valuations for Haite's stake in Haowei Huaxin are estimated between 3.7 to 5 billion USD, yet it is only valued at about 83 million USD on Haite's books. Losing control effectively jeopardizes a significant portion of Haite's value. In response to the seal seizure, Haite framed it as a "shareholder rights protection" action agreed upon by five shareholders. This mirrors a pattern in Chinese corporate disputes where seizing physical seals becomes a tactic to paralyze the opponent's daily operations, seen in past conflicts at companies like Dangdang and Bitmain. However, such actions don't resolve underlying ownership issues; the opposing party can report the seals stolen, declare them void, and apply for new ones, albeit with significant delay. The incident underscores how fragile corporate governance can devolve into physical confrontations over symbols of authority, with control ultimately determined by law and shareholding, not possession of a seal.

marsbit27m ago

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

marsbit27m ago

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

Bernstein's analysis of Moderna's 177% stock surge following positive Phase 3 results for its individualized neoantigen therapy (INT) in melanoma distinguishes fundamental drivers from market speculation. The clinical breakthrough is real: the INTerpath-001 trial met its primary and key secondary endpoints, providing crucial validation for mRNA technology in oncology beyond infectious diseases. However, Bernstein argues the magnitude of the stock move cannot be justified by this single trial's fundamentals alone. The surge was amplified by three key factors: 1) A re-rating of Moderna's mRNA platform potential for expansion into other cancers, 2) A massive short squeeze, given ~15% of shares were sold short pre-announcement, and 3) The compelling "cancer vaccine" narrative that fueled broader investor enthusiasm. While the melanoma success is significant, Bernstein cautions that replication in lung, kidney, and bladder cancers—which have different immunogenicity—is not guaranteed. Furthermore, INT's commercial model faces challenges: it's a personalized treatment, not a mass-market vaccine, implying higher production costs and potential margin pressures despite a projected multi-billion dollar peak sales opportunity. The report also notes sector rotation, with some funds moving from crowded AI/semiconductor trades into defensive healthcare stocks, adding further momentum. In conclusion, Bernstein maintains a "Market-Perform" rating and a $45 price target, far below the post-surge price. It views the current valuation as pricing in an optimistic multi-cancer platform success and efficient commercialization that are yet to be proven. The clinical inflection point is clear, but the earnings inflection point awaits validation across future trials and commercial execution.

marsbit27m ago

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

marsbit27m ago

Trading

Spot

Hot Articles

Discussions

Welcome to the HTX Community. Here, you can stay informed about the latest platform developments and gain access to professional market insights. Users' opinions on the price of S (S) are presented below.

活动图片